Effect of a late evening snack using branched-chain amino acid-enriched nutrients in patients undergoing hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma

Hepatology Research

Volumn 40, Issue 6, 2010, Pages 574-584

  Harima, Yohei ^a   Yamasaki, Takahiro ^a   Hamabe, Satoe ^a   Saeki, Issei ^a   Okita, Kohsuke ^a   Terai, Shuji ^a   Sakaida, Isao ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced hepatocellular carcinoma; Branched chain amino acid; Hepatic arterial infusion chemotherapy; Late evening snack; Nutritional therapy

Indexed keywords

BRANCHED CHAIN AMINO ACID; PREALBUMIN; TYROSINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; FOOD; FOOD INTAKE; GLUCOSE TOLERANCE; HUMAN; LATE EVENING SNACK; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NUTRIENT; NUTRITIONAL COUNSELING; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RESPIRATORY QUOTIENT;

EID: 77954369915     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2010.00665.x     Document Type: Article

References (41)

1. Nutritional status in cirrhosis. J Hepatol 1994, 21:317-25. Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis
2. Lautz HU, Selberg O, Korber J, Burger M, Muller MJ. Protein-calorie malnutrition in liver cirrhosis. Clin Investig 1992, 70:478-86.
3. Tajika M, Kato M, Mohri H. Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition 2002, 18:229-34.
4. Owen OE, Trapp VE, Reichard GA. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest 1983, 72:1821-32.
5. Swart GR, Zillikens MC, van Vuure JK, van den Berg JW. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. BMJ 1989, 299:1202-3.
6. Zillikens MC, van den Berg JW, Wattimena JL, Rietveld T, Swart GR. Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls. J Hepatol 1993, 17:377-83.
7. Miwa Y, Shiraki M, Kato M. Improvement of fuel metabolism by nocturnal energy supplementation in patients with liver cirrhosis. Hepatol Res 2000, 18:184-9.
8. Nakaya Y, Okita K, Suzuki K. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007, 23:113-20.
9. Guidelines for the use of parenteral and eternal nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 2002, 26:65SA-68SA. ASPEN Board of Directors and the Clinical Guidelines Task Force
10. Plauth M, Merli M, Konrup J, Weimann A, Ferenci P, Müller MJ. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr 1997, 16:43-55.
11. Okamoto M, Sakaida I, Tsuchiya M, Suzuki C, Okita K. Effect of late evening snack on the blood glucose level and energy metabolism in patients with liver cirrhosis. Hepatol Res 2003, 27:45-50.
12. Sakaida I, Tsuchiya M, Okamoto M, Okita K. Late evening snack and the change of blood glucose level in patients with liver cirrhosis. Hepatol Res 2004, 30S:67-72.
13. Tsuchiya M, Sakaida I, Okamoto M, Okita K. The effect of a late evening snack in patients with liver cirrhosis. Hepatol Res 2005, 31:95-103.
14. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across 5 continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006, 24:2137-50.
15. Kiyosawa K, Umemura T, Ichijo T. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 2004, 127:S17-26.
16. EI-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004, 127:S27-34.
17. Bosetti C, Levi F, Boffetta P, Lucchini F, Negri E, La Vecchia C. Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology 2008, 48:137-45.
18. Okuda K, Ohtsuki T, Obata H. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985, 56:918-28.
19. Yamasaki T, Kurokawa F, Shirahashi H. Novel arterial infusion chemotherapy using cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma. Hepatol Res 2002, 23:7-17.
20. Yamasaki T, Kimura T, Kurokawa F. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy. J Gastroenterol 2005, 40:70-8.
21. Takaki-Hamabe S, Yamasaki T, Saeki I. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: is the addition of subcutaneous interferon-α-2b beneficial? Hepatol Res 2009, 39:223-30.
22. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973, 60:646-9.
23. Merli M, Riggio O, Servi R. Increased energy expenditure in cirrhotic patients with hepatocellular carcinoma. Nutrition 1992, 8:321-5.
24. Macfie J, Burkinshaw L, Oxby C, Holmfield JH, Hill GL. The effect of gastrointestinal malignancy on resting energy expenditure. Br J Surg 1982, 69:443-6.
25. Poon RT, Yu W, Fan S, Wong J. Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial. Aliment Pharmacol Ther 2004, 19:779-88.
26. Takeshita S, Ichikawa T, Nakao K. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma. Nutr Res 2009, 29:89-93.
27. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer 2008, 20-4. Liver Cancer Study Group of Japan, 5th, edn., Tokyo, Kanehara & Co., in Japanese
28. Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 2003, 38:207-15.
29. Muller MJ, Pirlich M, Balks HJ. Glucose in liver cirrhosis: role of hepatic and non-hepatic influences. Eur J Clin Chem Clin Biochem 1994, 32:749-58.
30. Oken MM, Creech RH, Tormey DC. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5:649-55.
31. Okita M, Watanabe A, Nagashima H. Nutritional treatment of liver cirrhosis by branched-chain amino acid-enriched nutrient mixture. J Nutr Sci Vitaminol 1985, 31:291-303.
32. Nakamura I, Ochiai K, Imai Y, Moriyasu F, Imawari M. Restoration of innate host defense responses by oral supplementation of branched-chain amino acids in decompensated cirrhotic patients. Hepatol Res 2007, 37:1062-7.
33. Blackburn GL, Bistrian BR, Maini BS. Nutritional and metabolic assessment of the hospitalized patient. JPEN J Parenter Enteral Nutr 1977, 1:11-22.
34. Kaplan E, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958, 53:457-81.
35. Kawaguchi K, Araki K, Tobiume K, Tanaka N. p53 regulates glucose metabolism through an IKK-NF-kB pathway and inhibits cell transformation. Nat Cell Biol 2008, 10:611-18.
36. Kao JT, Chuah SK, Huang CC. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection. Liver Int 2007, 27:772-81.
37. Shenkin A. Serum prealbumin: is it a marker of nutritional status or of risk of malnutrition? Clin Chem 2006, 52:2177-9.
38. Urata Y, Okita K, Korenaga K, Uchida K, Yamasaki T, Sakaida I. The effect of supplementation with branched-chain amino acids in patients with liver cirrhosis. Hepatol Res 2007, 37:510-16.
39. Nishitani S, Takehana K, Fujitani S. Branched-chain amino acids improve glucose metabolism in rats with liver cirrhosis. Am J Physiol Gastrointest Liver Physiol 2005, 288:G1292-300.
40. Aoyama K, Tuchiya M, Mori K. Effect of a late evening snack in outpatients with cirrhosis. Hepatol Res 2007, 37:608-14.
41. Korenaga K, Korenaga M, Uchida K, Yamasaki T, Sakaida I. Effects of a late evening snack combined with alpha-glucosidase inhibitor on liver cirrhosis. Hepatol Res 2008, 38:1087-97.